Shp2f/fLysMCre tumor-bearing mice also exhibited enhanced T cell activation (Fig. 2g,h) and recruitment of CD4+ and CD8+ TEF cells in dLN (Fig. 2i,j). The gene discussed is CD8A; the disease is neoplasm.